Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer

被引:0
|
作者
Ahmed M. Mansour
Mona Abdelrahim
Mahmoud Laymon
Mamdouh Elsherbeeny
Mohammed Sultan
Ahmed Shokeir
Ahmed Mosbah
Hassan Abol-Enein
Amira Awadalla
Eunho Cho
Vikram Sairam
Taeeun D. Park
Muhammad Shahid
Jayoung Kim
机构
[1] Mansoura University,Urology and Nephrology Center
[2] University of Texas Health Science Center,Departments of Surgery and Biomedical Sciences
[3] University of California Los Angeles,undefined
[4] University of California,undefined
[5] Samuel Oschin Comprehensive Cancer Institute,undefined
[6] Cedars Sinai Medical Center,undefined
来源
BMC Urology | / 18卷
关键词
EGFR; Bladder cancer; Survival; Adjuvant chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer
    Mansour, Ahmed M.
    Abdelrahim, Mona
    Laymon, Mahmoud
    Elsherbeeny, Mamdouh
    Sultan, Mohammed
    Shokeir, Ahmed
    Mosbah, Ahmed
    Abol-Enein, Hassan
    Awadalla, Amira
    Cho, Eunho
    Sairam, Vikram
    Park, Taeeun D.
    Shahid, Muhammad
    Kim, Jayoung
    BMC UROLOGY, 2018, 18
  • [2] Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
    Katayama, Satoshi
    Schuettfort, Victor M.
    Pradere, Benjamin
    Mori, Keiichiro
    Mostafaei, Hadi
    Quhal, Fahad
    Motlagh, Reza Sari
    Laukhtina, Ekaterina
    Grossmann, Nico C.
    Aydh, Abdulmajeed
    Rajwa, Pawel
    Koenig, Frederik
    Karakiewicz, Pierre, I
    Haydter, Martin
    Moschini, Marco
    Abufaraj, Mohammad
    Lotan, Yair
    Lee, Richard K.
    Quoc-Dien Trinh
    Comperat, Eva
    Teoh, Jeremy
    Nasu, Yasutomo
    Shariat, Shahrokh F.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3091 - 3102
  • [3] Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
    Satoshi Katayama
    Victor M. Schuettfort
    Benjamin Pradere
    Keiichiro Mori
    Hadi Mostafaei
    Fahad Quhal
    Reza Sari Motlagh
    Ekaterina Laukhtina
    Nico C. Grossmann
    Abdulmajeed Aydh
    Pawel Rajwa
    Frederik König
    Pierre I. Karakiewicz
    Martin Haydter
    Marco Moschini
    Mohammad Abufaraj
    Yair Lotan
    Richard K. Lee
    Quoc-Dien Trinh
    Eva Compérat
    Jeremy Teoh
    Yasutomo Nasu
    Shahrokh F. Shariat
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3091 - 3102
  • [4] Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancer
    McHugh, LA
    Griffiths, TRL
    Kriajevska, M
    Symonds, RP
    Mellon, JK
    UROLOGY, 2004, 63 (04) : 619 - 624
  • [5] Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancer
    Colquhoun, A. J.
    Sundar, S.
    Rajjayabun, P. H.
    Griffiths, T. R. L.
    Symonds, R. P.
    Mellon, J. K.
    CLINICAL ONCOLOGY, 2006, 18 (09) : 702 - 709
  • [6] Muscle-invasive bladder cancer
    Kuebler, H.
    Gschwend, J. E.
    ONKOLOGE, 2012, 18 (11): : 977 - +
  • [7] Muscle-Invasive Bladder Cancer
    Hasan, Shaakir
    Chhabra, Arpit M.
    Choi, J. Isabelle
    Simone, Charles B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : 309 - 310
  • [8] Muscle-invasive bladder cancer
    Buchler, Jakob
    Gschwend, Juergen E.
    Retz, Margitta
    Schmid, Sebastian C.
    UROLOGE, 2021, 60 (06): : 769 - 775
  • [9] Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer
    Zhao, Yu-gang
    Shi, Bing-yi
    Qian, Ye-yong
    Bai, Hong-wei
    Xiao, Li
    He, Xiu-yun
    TUMORI JOURNAL, 2014, 100 (06): : E273 - E281
  • [10] Bladder preservation in muscle-invasive bladder cancer
    Stackl, W
    Baierlein, M
    Albrecht, W
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (03): : 357 - 360